One recent study looked at screening based on age and family history, while another looked at the effectiveness of fecal immunochemical testing with and without postpolypectomy surveillance colonoscopy.
A review found that susceptibility-guided therapy may be the superior first-line treatment for H. pylori infection in areas with high antibiotic resistance, while a study of trial participants with 26.5 years of follow-up showed that H. pylori
A systematic review and meta-analysis assessed which interventions may improve hepatitis C virus (HCV) testing, linkage to care, and treatment initiation, while a randomized trial found that an accessible care model may be superior to facilitated
Recent studies found evidence of long-term safety and efficacy of fecal microbiota transplantation (FMT) for irritable bowel syndrome and other GI diseases.
The American Gastroenterological Association released a clinical practice update on using noninvasive colorectal cancer (CRC) screening options, and recent studies focused on fecal immunochemical test screening programs.
Recent studies found associations between nonalcoholic fatty liver disease (NAFLD) and coronary artery disease, sarcopenia, and mortality.
Two studies this month focused on the accuracy of serological tests for detecting celiac disease and the impacts of delayed diagnosis, while two others evaluated group-based education and a more restrictive diet as potential add-on treatments to a
Recent studies found that patients exposed to antibiotics had greater odds of developing colorectal cancer (CRC) and that obesity at different ages during early adulthood was strongly associated with an increased risk of early-onset CRC.
In the past month, researchers assessed potential treatments of irritable bowel syndrome (IBS), reviewed likely causes of the condition, and quantified the daily challenges facing patients with IBS.
Recent research has found that patients with inflammatory bowel disease (IBD) may have increased risk of Parkinson's disease and that this risk may be modified by anti-tumor necrosis factor therapy.